Browsing by Author "Gupta, A.K."

Now showing 1 - 4 of 4

Asian Journal of Psychiatry and Psychiatry in Asia: Time to reconsider human resources to represent cultural diversity in Asia
(Elsevier, 2021) Shoib, S.; Gupta, A.K.; Kar, S.K.; Chandradasa, M.; Menon, V.; Ullah, I.; Thuzar, M.; Arafat, S.M.Y.
No abstract available
Novel report on congenital talipes equinovarus (CTEV) following olanzapine exposure during pregnancy: case report and short review.
(Springer,New York, 2022) Gyawali, R.; Baral, A.; Upreti, D.; Yadav, C.B.; Gupta, A.K.; Chandradasa, M.; Shoib, S.
Olanzapine is widely used during pregnancy to manage mood and psychotic disorders with overall beneficial effects. There have been past reports of olanzapine exposure during early pregnancy and clubfoot in two newborns from India and Israel. We report a woman in Nepal diagnosed with schizophrenia and treated with olanzapine throughout the pregnancy delivering a baby boy with congenital talipes equinovarus deformity. Like in many other low-income settings, pregnancy was unplanned, and pre-conception counselling was not done. Research in mice has revealed the negative effects of olanzapine on bone development. Further reports would strengthen this potential association between exposure to olanzapine in the first trimester and the occurrence of clubfoot in the baby.
Parity of esteem: A global COVID‑19 vaccination approach for people with mental illnesses, based on facts from 34 countries; recommendations and solutions
(Medknow Publications, 2024) Shoib, S.; Saeed, F.; Philip, S.; Chandradasa, M.; Das, S.; de Filippis, R.; Yousaf, Z.; Ojeahere, M.; Gad, H.K.; Yadivel, R.; Legris, Z.; Jatchavala, C.; Paul, R.; Gupta, A.K.; Handuleh, J.I.M.; Gürcan, A.; Costa, M.P.D.; Dannatt, L.; Ahmad, A.R.; Jaguga, F.; Saleem, S.M.; Sawitri, B.; Ari, N.; Islam, M.S.; Haque, M.A.; Őri, D.; Chumakov, E.; Swed, S.; Roza, T.H.; Islam, S.M.S.
BACKGROUND: The coronavirus disease (COVID 19) pandemic, caused by the severe acute respiratory syndrome coronavirus 2 (SARS CoV 2), has detrimental effects on physical and mental health. Patients with severe mental illness are at higher risk of contracting the virus due to social determinants of health. Vulnerable populations include the elderly, people with pre existing conditions, and those exposed to SARS CoV 2. Unfortunately, only a few countries have updated vaccination strategies to prioritize patients with mental illnesses. Therefore, we aimed to explore whether individuals with mental disorders are prioritized in vaccine allocation strategies in different world regions. They are often neglected in policymaking but are highly vulnerable to the threatening complications of COVID 19. METHODS: A questionnaire was developed to record details regarding COVID 19 vaccination and prioritizations for groups of persons with non communicable diseases (NCDs), mental disorders, and substance use disorders (SUDs). NCDs were defined according to the WHO as chronic diseases that are the result of a combination of genetic, physiological, environmental, and behavioral factors such as cardiovascular diseases, cancer, respiratory diseases, and diabetes. RESULTS: Most countries surveyed (80%) reported healthcare delivery via a nationalized health service. It was found that 82% of the countries had set up advisory groups, but only 26% included a mental health professional. Most frequently, malignancy (68%) was prioritized followed by diabetes type 2 (62%) and type 1 (59%). Only nine countries (26%) prioritized mental health conditions. CONCLUSION: The spread of the coronavirus has exposed both the strengths and flaws of our healthcare systems. The most vulnerable groups suffered the most and were hit first and faced most challenges. These findings raise awareness that patients with mental illnesses have been overlooked in immunization campaigns. The range of their mortality, morbidity, and quality of life could have widened due to this delay.
Religion, spirituality, and coping among the psychiatric population: a narrative review
(Academy Publisher, 2024) Shoib, S.; Das, S.; Gupta, A.K.; Ullah, I.; Javed, S.; Nocera, A.; Kar, S.K.; Chandradasa, M.; de Filippis, R.
BACKGROUND AND AIMS: The impact of religiosity and spirituality on mental health is still far to be adequately explored. Evidence-based data gathering papers that bring together various perspectives and facets of religion in the mentally ill population is needed. Therefore, we conducted this review to summarise evidence on the subject and raise awareness. METHODS: We searched the literature using generic terms for ‘mental health and psychiatry’, ‘beliefs’, ‘religion’, ‘religious involvement’, ‘religiosity’, ‘spiritual aspects’, and ‘spirituality’, finally summarising all appropriate references. However, for this narrative revision, we collected papers addressing various perspectives, data, and facets of religion in the mentally ill population, a subject with theoretical and practical implications in mental health. RESULTS: The initial literature search found 21,723 total results: 1,723 from PubMed/Medline and Scopus, and up to 20,000 from Google Scholar, Science Direct, and Web of Science. After removing repetitions and applying inclusion and exclusion criteria, only six studies were included in this review on religion as an adaptive resource, and nine studies on religion, spirituality, and mental health. CONCLUSIONS: Evidence-based studies on the topic are still challenging to develop while maintaining a high scientific value. Notwithstanding this, religion and spirituality can have positive/negative clinical implications depending on how they are managed. Indeed, it can reduce suicidal risk, relieve depressive and anxious symptoms, and improve patients’ and caregivers’ coping and resilience. Nevertheless, it can enhance guilt, worsen/ generate obsessions, and compulsions in the obsessive-compulsive disorder and determine or associate with mystical-religious delusions in the maniacal phase of bipolar disorder.